It's a bottle of wine with a purpose.
Humanitas, which is Latin for "humanity" or "philanthropy," started about 12 years ago with a very specific mission.
"I had this crazy vision. This vision was that I wanted to make wine so good, that they can change the world. And I meant by so good, was that they clearly would be great wines. That was a given. But I also wanted to do something good for the world," said founder of Humanitas, Judd Wallenbrock.
Each charity Humanitas works with receives 100% of the profits from wine sold in the local community it serves.
Because the founder, Judd Wallenbrok, doesn't take a paycheck from the Humanitas, he does have a full-time job working with other vineyards.
That's how he met two Sanford doctors at their own vineyard in California, and learned about the Edith Sanford Breast Cancer Foundation.
"They were really doing he genomics sequencing. The actual DNA work to find a cure to eradicate cancer. And there's a lot of people out there doing awareness for it, but who's doing the next step? Well these guys are," said Wallenbrock.
"Really the future will be in unlocking each person's genomic code. To understand what's driving their breast cancer, or what risk factors they have from a genomic level and to really control, or prevent or cure," said Eva May, Edith Sanford Breast Cancer Foundation.
Eva May with the Edith Sanford Foundation, says money is always an obstacle with funding this type of research.
"When we have all these different plans for the research that can be done on a lot of different levels, and knowing ok once we discover this, then we'll have to go and work on this. And there's so much more to do to ultimately end breast cancer. It's just millions, and millions and millions of dollars. But it goes to good use," said May.
While Humanitas wine may not bring in millions, Wallenbrock hopes to make a difference by "drinking charitably."
"That's really what we're encouraging. All you have to do is enjoy wine, and vicariously you're giving back to find a cure for breast cancer," said Wallenbrock.